Full View

A Randomized, Double‐Blind, Placebo‐Controlled Parallel‐Group Study to Assess the Efficacy and Safety of Nebivolol, a Novel β‐Blocker, in Patients With Mild to …

RJ Weiss, MA Weber, AA Carr… - The Journal of Clinical …, 2007 - Wiley Online Library
This double‐blind, multicenter, randomized placebo‐controlled study evaluated the
antihypertensive efficacy and safety of nebivolol, a selective β1‐adrenoreceptor blocker with …
被引用次数：64 相关文章

A randomized, double-blind, placebo-controlled parallel-group study to assess the efficacy and safety of nebivolol, a novel beta-blocker, in patients with mild to …

RJ Weiss, MA Weber, AA Carr, WA Sullivan - 2007 - pubmed.ncbi.nlm.nih.gov
This double-blind, multicenter, randomized placebo-controlled study evaluated the
antihypertensive efficacy and safety of nebivolol, a selective beta1-adrenoreceptor blocker …
[HTML] nih.gov

[HTML][HTML] A Randomized, Double‐Blind, Placebo‐Controlled Parallel‐Group Study to Assess the Efficacy and Safety of Nebivolol, a Novel β‐Blocker, in Patients With …

RJ Weiss, MA Weber, AA Carr… - The Journal of Clinical …, 2007 - ncbi.nlm.nih.gov
This double‐blind, multicenter, randomized placebo‐controlled study evaluated the
antihypertensive efficacy and safety of nebivolol, a selective β 1‐adrenoreceptor blocker …

A randomized, double-blind, placebo-controlled parallel-group study to assess the efficacy and safety of nebivolol, a novel beta-blocker, in patients with mild to …

RJ Weiss, MA Weber, AA Carr… - Journal of Clinical …, 2007 - europepmc.org
This double‐blind, multicenter, randomized placebo‐controlled study evaluated the
antihypertensive efficacy and safety of nebivolol, a selective β 1‐adrenoreceptor blocker …

[引用][C] A randomized, double-blind, placebo-controlled parallel-group study to assess the efficacy and safety of nebivolol, a novel β-blocker, in patients with mild to …

RJ WEISS, MA WEBER, AA CARR… - The Journal of clinical …, 2007 - Wiley